Recurrent glomerular disease in the kidney allograft

Area of Science:

• Nephrology
• Transplantation Immunology
• Glomerular Diseases

Background:

• Glomerulonephritis accounts for approximately 15% of end-stage renal disease.
• Kidney allograft recipients face the risk of recurrent glomerular disease, potentially leading to graft loss.
• The presentation and prevalence of recurrent disease vary based on diagnostic methods and follow-up duration.

Purpose of the Study:

• To review the epidemiology, diagnosis, and treatment of common glomerular diseases that recur post-kidney transplant.
• To provide insights into managing recurrent focal and segmental glomerulosclerosis, membranous nephropathy, membranoproliferative glomerulonephritis, immunoglobulin A nephropathy, and lupus nephritis.

Main Methods:

• Literature review focusing on recurrent glomerular diseases in kidney transplant recipients.
• Analysis of factors influencing recurrence rates, including biopsy protocols and diagnostic techniques.
• Synthesis of current knowledge on the management of specific recurrent glomerulonephritides.

Main Results:

• Recurrent glomerular diseases pose a significant threat to kidney allograft survival.
• Immunosuppression can modulate disease activity, leading to subclinical or overt forms.
• The review details five specific glomerulonephritides prone to recurrence: FSGS, MN, MPGN, IgAN, and LN.

Conclusions:

• Understanding the patterns of recurrence is crucial for optimizing post-transplant care.
• Timely diagnosis and appropriate treatment strategies are essential to preserve allograft function.
• This review serves as a guide for clinicians managing transplant patients with recurrent glomerular diseases.